These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3217461)

  • 1. Behavioral indications for serotonin receptor hypersensitivity in panic disorder.
    Kahn RS; Wetzler S; van Praag HM; Asnis GM; Strauman T
    Psychiatry Res; 1988 Jul; 25(1):101-4. PubMed ID: 3217461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder.
    Kahn RS; Asnis GM; Wetzler S; van Praag HM
    Psychopharmacology (Berl); 1988; 96(3):360-4. PubMed ID: 2906153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noradrenergic and serotonergic receptor system function in panic disorder and depression.
    Heninger GR; Charney DS; Price LH
    Acta Psychiatr Scand Suppl; 1988; 341():138-50. PubMed ID: 3048049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin receptor sensitivity and aggression.
    Wetzler S; Kahn RS; Asnis GM; Korn M; van Praag HM
    Psychiatry Res; 1991 Jun; 37(3):271-9. PubMed ID: 1891509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH
    Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.
    Charney DS; Woods SW; Goodman WK; Heninger GR
    Psychopharmacology (Berl); 1987; 92(1):14-24. PubMed ID: 3110824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5-HT3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteers.
    Silverstone PH; Cowen PJ
    Biol Psychiatry; 1994 Sep; 36(5):309-16. PubMed ID: 7993957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects.
    Kahn RS; Wetzler S; Asnis GM; Kling MA; Suckow RF; van Praag HM
    Psychiatry Res; 1991 Apr; 37(1):25-34. PubMed ID: 1650487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panic disorder: a presynaptic serotonin defect?
    Kahn RS; van Praag HM
    Psychiatry Res; 1990 Feb; 31(2):209-10. PubMed ID: 2326399
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholism.
    George DT; Nutt DJ; Rawlings RR; Phillips MJ; Eckardt MJ; Potter WZ; Linnoila M
    Biol Psychiatry; 1995 Jan; 37(2):112-9. PubMed ID: 7718674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects.
    Asnis GM; Wetzler S; Sanderson WC; Kahn RS; van Praag HM
    Psychiatry Res; 1992 Jul; 43(1):65-76. PubMed ID: 1438618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects.
    Klein E; Zohar J; Geraci MF; Murphy DL; Uhde TW
    Biol Psychiatry; 1991 Nov; 30(10):973-84. PubMed ID: 1756202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin function in panic disorder: intravenous administration of meta-chlorophenylpiperazine.
    Wetzler S; Asnis GM; DeLecuona JM; Kalus O
    Psychiatry Res; 1996 Sep; 64(2):77-82. PubMed ID: 8912948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks.
    Kalus O; Kahn RS; Wetzler S; Asnis GM; van Praag HM
    Biol Psychiatry; 1990 Dec; 28(12):1053-7. PubMed ID: 2288999
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet serotonin uptake in panic disorder: comparison with normal controls and the effect of treatment.
    Norman TR; Gregory MS; Judd FK; Burrows GD; McIntyre IM
    Aust N Z J Psychiatry; 1988 Dec; 22(4):390-5. PubMed ID: 2907288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine.
    Simeon D; Hollander E; Stein DJ; DeCaria C; Cohen LJ; Saoud JB; Islam N; Hwang M
    Psychiatry Res; 1995 Sep; 58(2):161-4. PubMed ID: 8570768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects.
    Kahn RS; Kalus O; Wetzler S; Cahn W; Asnis GM; van Praag HM
    Psychiatry Res; 1990 Aug; 33(2):189-98. PubMed ID: 2243896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased 5-HT-mediated prolactin release in major depression.
    Anderson IM; Ware CJ; da Roza Davis JM; Cowen PJ
    Br J Psychiatry; 1992 Mar; 160():372-8. PubMed ID: 1562864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactate-induced panic attacks: possible involvement of serotonin reuptake stimulation.
    Lingjaerde O
    Acta Psychiatr Scand; 1985 Aug; 72(2):206-8. PubMed ID: 4050513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.
    Brewerton TD; Mueller EA; Lesem MD; Brandt HA; Quearry B; George DT; Murphy DL; Jimerson DC
    Arch Gen Psychiatry; 1992 Nov; 49(11):852-61. PubMed ID: 1444722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.